Advertisement

Glial Cells and Products of Activated Inflammatory Cells: Implications for Pathogenesis and Treatment of Multiple Sclerosis

  • R. P. Lisak
Conference paper

Abstract

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system of unknown etiology, but a disease in which immunopathologic events are likely important [1]. It is a chronic disease, frequently with an clinically relapsing course [2], but the pathologic processes may actually be continuous, although accentuated at times [3]. It also has a restricted age distribution, with the peak onset between 20 and 40 years of age. In addition to the inflammation, which is predominantly made up of monocyte-macrophage-microglia and lymphocytes and/ or their progeny, and demyelination, the other characteristic pathologic feature is gliosis [4]. This gliosis relates to the astrocytes, although there is some controversy as to whether these cells become more prominent, increase in number, or both.

Keywords

Multiple Sclerosis Major Histocompatibility Complex Glial Cell Multiple Sclerosis Patient Experimental Allergic Encephalomyelitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Lisak RP (1980) Multiple sclerosis: evidence for immunopathogenesis. Neurology 30(2): 99–105PubMedGoogle Scholar
  2. 2.
    Poser CM, Alter M, Sibley WA, Scheinberg LC (1984) Demyelinating diseases, 129. Multiple sclerosis. In: Rowland LP (ed) Merritt’s Textbook of Neurology. Lea and Febinger, Philadelphia, pp 593–611Google Scholar
  3. 3.
    Naharona ABC, Richman DP, Arnason BGW (1980) Detection of in vivo stimulated cerebrospinal fluid lymphocytes by flow cytometry inpatients with multiple sclerosis. E Engl J Med 303:713–717CrossRefGoogle Scholar
  4. 4.
    Prineas JW (1985) The neuropathology of multiple sclerosis. In: Koetsier JC (ed) Clincial handbook of Neurology, vol 47, demyelinating diseases. Elsevier, Amsterdam, pp 213–257Google Scholar
  5. 5.
    Reder AT, Arnason BGW (1985) Immunology of multiple sclerosis. In: Koetsier JC (ed) Clinical Handbook of Neurology, vol 47, demyelinating diseases. Elsevier, Amsterdam, pp 337–396Google Scholar
  6. 6.
    Lisak RP (1986) Immunologic abnormalities. In: McDonald WL, Silberberg DH (eds) Multiple sclerosis, Butterwort medical reviews, Neurology, vol 6. Butterworths, London pp 74–98Google Scholar
  7. 7.
    Lisak RP, Zweiman B, Burns JB, Rostami A, Silberberg DH (1984) Immune responses to myelin antigens in multiple sclerosis. Ann NY Acad Sci 436:221–230PubMedCrossRefGoogle Scholar
  8. 8.
    Fontana A, Grob PJ (1984) Lymphokines and the brain (DeWeck, AL guest ed). Springer Semin. Immunopathol. 6:375–386Google Scholar
  9. 9.
    Fontana A, Fierz W (1985) The endothelium-astrocyte immune control system of the brain. (Steck AJ, Lisak RP guest eds). Springer Semin Immunopathol 8:57–70Google Scholar
  10. 10.
    Hofman FM, von Hanwehr RI, Dinarello CA, Nigel SB, Hinton D, Merrill JE (1986) Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J Immunol 136:3239–3248PubMedGoogle Scholar
  11. 11.
    Fontana A, Fierz W, Wekerle H (1984) Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307:276CrossRefGoogle Scholar
  12. 12.
    Fontana A, Kristensen F, Dubs R, Gemsa D, Weber F (1982) production of prostaglandin R and interleukin-1 like factors by cultured astrocytes and C-6 glioma cells. J Immunol 129:2413–2419PubMedGoogle Scholar
  13. 13.
    DuBois JH, Bolton C, Cuzner ML (1986) The production of prostaglandin and the regulation in neonatal primary mixed glial cultures. J Neuroimmunol 11:277–285PubMedCrossRefGoogle Scholar
  14. 14.
    Naske W, Lantzen H, Lange T, Keller E (1982) Phagocytic activity of glial cells in culture. Exper Cell Res 142:437–445CrossRefGoogle Scholar
  15. 15.
    Bever CT, Whitaker JN (1985) Proteinases in inflammatory demyelinating disease. (Steck AJ, Lisak RP guest eds). Springer Semin Immunopathol 8:235–250Google Scholar
  16. 16.
    Fontana A, Greider A, Arrenbrecht ST, Grob I (1980) In vitro stimulation of glial cells by a lymphocyte-produced factor. J Neurol Sci 46:55–62PubMedCrossRefGoogle Scholar
  17. 17.
    Grulian D, Lachman LB (1985) Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228:497–499CrossRefGoogle Scholar
  18. 18.
    Miller RH, Abney ER, David S, French-Constant C, Lindsay R, Patel R, Stone J, Raff MC (1986) Is reactive gliosis a property of a distinct subpopulation of astrocytes? J Neurosci 6:22–29PubMedGoogle Scholar
  19. 19.
    Raff MC, Nuller RH, Noble M (1983) A glial progenitor cell that develops into an astrocyte or oligodendrocyte depending on culture medium. Nature 303:390–396PubMedCrossRefGoogle Scholar
  20. 20.
    Raff MC, Abney ER, Cohen J, Lindsay R, Noble M (1983) Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J Neurosci 3:1289–1300PubMedGoogle Scholar
  21. 21.
    Waxmann SG (1986) The astrocyte as a component of the node of Ranvier. Trends Neurosci: 250–253Google Scholar
  22. 22.
    Fontana A, Dubs R, Merchant R, Balsiger S, Grob PJ (1981) Glial cell stimulation factor (GSF): a new lymphokine. Part I. Cellular sources and partial purification of murine GSF, role of cytoskeleton and protein synthesis in its production. J Neuroimmunol 2:55–71CrossRefGoogle Scholar
  23. 23.
    Fontana A, Otz U, De Week AL, Grob PJ (1981) Glial cell stimulating factor (GSF): a new lymphokine, part II. Cellular sources and partial purification of human GSF. J Neuroimmunol 2:73–81CrossRefGoogle Scholar
  24. 24.
    Lisak RP, Kuchmy D, Pleasure DE unpublished observationsGoogle Scholar
  25. 25.
    Lisak RP, Kuchmy D, Guerrero F, Pleasure DE (1986) γ-interferon and interleukin-1 are not mitogenetic for neonatal Schwann cells in vitro. Neurology 36 (Suppl): 313Google Scholar
  26. 26.
    Merrill JE, Kutsunai S, Mohlstrom C, Hofman F, Groopman J, Golde DW (1984) Proliferation of astroglia and oligodendroglia in response to human T-cell derived factors. Science 224:1428PubMedCrossRefGoogle Scholar
  27. 27.
    Benveniste EN, Merrill JE, Kaufman SE, Golde DW, Gasson JC (1985) Purification and characterization of a human ? lymphocyte-derived glial growth-promoting factor. Proc Natl Acad Sci USA 82:3930–3934PubMedCrossRefGoogle Scholar
  28. 28.
    Suzumura A, Silberberg DH, Lisak RP (1986) The expression of MHC antigens on oligodendrocytes. Induction of polymorphic H-2 expression by lymphokines. J Neuroimmunol 11:179–190PubMedCrossRefGoogle Scholar
  29. 29.
    Benveniste EN, Merrill JE (1986) Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Nature 321:610–613PubMedCrossRefGoogle Scholar
  30. 30.
    Lisak RP, Sobue G, Kuchmy D, Burns JB, Pleasure DE (1985) Products of activated lymphocytes stimulate Schwann cell mitosis in vitro. Neurosci Lett 57:105–111PubMedCrossRefGoogle Scholar
  31. 31.
    Hirsch MR, Wietzerkin J, Pierres M, Goridis C (1983) Expression of la antigens by cultured astrocytes treated with gamma-interferon. Neurosci Lett 41:199–204PubMedCrossRefGoogle Scholar
  32. 32.
    Wong GHW, Bartlett PF, Clark-Lewis I, Battye F, Schraeder J (1984) Inducible expression of H-2 and la antigen on brain cells Nature 310:688–691Google Scholar
  33. 33.
    Wong GHW, Bartlett PF, Clark-Lewis I, McKimm-Breshken JL, Schroeder W (1985) Interferon-γ induces the expression of H-2 and la antigens on brain cells. J Neuroimmunol 7:225–279Google Scholar
  34. 34.
    Suzumura A, Silberberg DH (1985) Expression of H-2 antigen on oligodendrocytes is induced by soluble factors from Concanavalin-A activated T-cells. Brain Res 336:171–175PubMedCrossRefGoogle Scholar
  35. 35.
    DuBois JH, Hammond-Tooke GD, Cuzner ML (1986) Expression of major histocompatibility complex antigens in neonatal rat primary mixed glial cultures. J Neuroimmunol 9:363–377CrossRefGoogle Scholar
  36. 36.
    Zinkernagel RM, Doherty PC (1979) MHC restricted cytotoxic T-cells: studies on the biological role on polymorphic major transplantation antigens, determining T-cell restriction specificity function and responsiveness. Adv Immunol 27:52–177Google Scholar
  37. 37.
    Suzumura A, Lavi E, Weiss SR, Silberberg DH (1986) Neurotropic coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science 232:991–993PubMedCrossRefGoogle Scholar
  38. 38.
    Zweiman J, Lisak RP (1986) Lymphocyte phenotypes in the MS lesion. What do they mean? Ann Neurol 19:588–589CrossRefGoogle Scholar
  39. 39.
    Lisak RP, Hirayama M, Kuchmy D, Rosenzweig A, Kim SU, Pleasure DE, Silberberg DH (1983) Cultured human and rat oligodendrocytes and rat Schwann cells do not have immune response gene associated antigen (la) on their surface. Brain Res 289:285–292PubMedCrossRefGoogle Scholar
  40. 40.
    Cashman NR, Nohorona A (1986) Accessory cell competence of ovine oligodendrocytes in mitogenic activation of human peripheral T-cells. J Immunol 136:4460–4463PubMedGoogle Scholar
  41. 41.
    Ting JPY, Shigekawa BL, Linthicum DS, Weiner LP, Frelinger JA (1981) Expression and synthesis of murine immune response-associated (Ia) antigen by brain cells. Proc Natl Acad Sci USA 78:3170–3174PubMedCrossRefGoogle Scholar
  42. 42.
    Ting JPY, Nixon DF, Weiner LP, Frelinger JA (1983) Brain Ia antigens have a bone marrow origin. Immunogenetics 17:295–301PubMedCrossRefGoogle Scholar
  43. 43.
    Traugott U, Scheinberg LC, Raine CS (1985) On the presence of la-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuroimmunol 8:1–14PubMedCrossRefGoogle Scholar
  44. 44.
    Sun D, Wekerle H (1986) la restricted encephalitogenic ? lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature 320:70–72PubMedCrossRefGoogle Scholar
  45. 45.
    Hickey WF, Osborn JP, Kirbi WM (1985) Expression of Ia molecules by astrocytes during acute experimental allergic enephalomyelitis in the Lewis rat. Cell Immunol 91:528–535PubMedCrossRefGoogle Scholar
  46. 46.
    Vass K, Lassmann H, Wekerle H, Wisniewski HM (1986) The distribution of la antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol 70:149–160PubMedCrossRefGoogle Scholar
  47. 47.
    Kornstein MJ, Brooks JJ, Anderson AO, Levinson AL, Lisak RP, Zweiman J (1984) The immunohistology of the thymus in myasthenia gravis. Am J Pathol 147:184–194Google Scholar
  48. 48.
    Sobel RA, Calvin RB (1985) The immunopathology of experimental allergic encephalomyelitis (EAE). Differential in situ expression of Strain 13 Ia on endothelial and inflammatory cells of (Strain 2+Strain 13) F1 guinea pigs with EAE. J Immunol 134:2333–2337PubMedGoogle Scholar
  49. 49.
    Matsumato Y, Hara N, Tanaka R, Fujiwara M (1986) Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to la positive cells with dendritic morphology. J Immunol 136:3668–3676Google Scholar
  50. 50.
    Traugott U (1985) Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelination lesions. (Steck AJ, Lisak RP guest eds) Springer Semin Immunopathol 8:71–96Google Scholar
  51. 51.
    Traugott U, Raine CS (1985) Multiple sclerosis. Evidence for antigen presentation in situ by endothelial cells and astrocytes. J Neurol Sci 69:365–370PubMedCrossRefGoogle Scholar
  52. 52.
    McCarron RM, Spatz M, Kempski U, Hogan RN, Muehl L, McFarlin DE (1986) Interaction between myelin basic protein-sensitized D lymphocytes and murine cerebrovascular vascular endothelial cells. J Immunol 137:3428–3435PubMedGoogle Scholar
  53. 53.
    Sergott RC, Brown MJ, Polenta RM-D, Lisak RP, Silberberg DH (1985) Optic nerve demyelination induced by human serum: patients with multiple sclerosis or optic neuritis and normal subjects, Neurology 35:1438–1442PubMedGoogle Scholar
  54. 54.
    Hirayama M, Lisak RP, Silberberg DH (1986) Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls. Neurology 36:276–278PubMedGoogle Scholar
  55. 55.
    Suzumura A, Lisak RP, Silberberg DH (1986) Serum cytotoxicity to oligodendrocytes in multiple sclerosis and controls: assessment by 51Cr release assay. J Neuroimmunol 11:137–147PubMedCrossRefGoogle Scholar
  56. 56.
    Neighbour PA, Bloom BR (1979) Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis. Proc Natl Acad Sci USA 76:476–480PubMedCrossRefGoogle Scholar
  57. 57.
    Neighbour PA (1984) Studies of interferon production and natural killing by lymphocytes from multiple sclerosis patients. Ann NY Acad Sci 436:181–191PubMedCrossRefGoogle Scholar
  58. 58.
    Salonen R, Ilonen J, Reunanen M, Nikoloskelainen J, Salmi A (1982) PPD-, PWM-, and PHA-induced interferon in stable multiple sclerosis: association with HLA-Dw2 antigen and clinical variables. Ann Neurol 11:279–284PubMedCrossRefGoogle Scholar
  59. 59.
    Vervhet G, Claeys H, van Hover H, Carton H, Vermylen C, Meulepas E, Billiau A (1983) Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patients. J Neurol Sci 60:134–150Google Scholar
  60. 60.
    Santoli D, Hall W, Kastroukoff L, Lisak RP, Perussia B, Trinchieri G, Koprowski ? (1978) Cytotoxic activity and interferon production by lymphocytes from patients with multiple sclerosis. J Immunol 126:1274–1278Google Scholar
  61. 61.
    Kaudewitz A, Zander S, Abb J, Ziegler-Heitbrock HW, Riethmuller G (1983) Genetic influence on natural cytotoxicity and interferon production in multiple sclerosis in monozygotic discordant twins. Hum Immunol 7:51–58PubMedCrossRefGoogle Scholar
  62. 62.
    Tovell DR, McRobbie IA, Warren KG, Tyrrell DL (1983) Interferon production by lymphocytes from multiple sclerosis and non-MS patients. Neurosci Behav Physiol 33:640–643Google Scholar
  63. 63.
    Pannitch HS, Haley AS, Hirsch RL, Johnson KP (1986) A trial of gamma interferon in multiple sclerosis: clinical results. Neurology 36(Suppl 1):285Google Scholar
  64. 64.
    Lisak RP (1986) Interferon and multiple sclerosis. Ann Neurol 20:273PubMedCrossRefGoogle Scholar
  65. 65.
    Taylor-Papadimitrou J (ed) (1985) Interferons. Their Impact in Biology and Medicine, Oxford University Press, OxfordGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • R. P. Lisak
    • 1
    • 2
  1. 1.Departments of Neurology and Immunology and MicrobiologyWayne State University School of MedicineDetroitUSA
  2. 2.University of Pennsylvania School of MedicinePhialdelphiaUSA

Personalised recommendations